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Mouse  peritoneal  macrophages obtained after the  injection of substances which 
produce  a  local  inflammatory response  in  the  peritoneal  cavity such  as  Brewer's 
thioglycollate, differ in a number of functional and biochemical aspects from resident 
cells. These elicited or stimulated macrophages have been shown to exhibit changes 
in  their endocytic capacity  (1,  2),  their expression of several  membrane-associated 
enzymes (3, 4), their synthesis and secretion of neutral proteinases, including plasmin- 
ogen activator (5-8), their motility and their ability to rapidly spread on surfaces to 
which they have become attached (9). It has been noted that in vitro spreading may 
be a consequence and correlate of in vivo macrophage activation by immunological 
mechanisms as it is a  property of cells activated in vivo by Bacille Calmette-Gu~rin 
injections or by other means of lymphocyte stimulation (10-12). Thus, rapid spreading 
of freshly  explanted  macrophages  has  been  taken  as  an  early  expression  of the 
morphological, functional and biochemical changes occurring upon  cell  activation 
(13).  Previous  studies  have  demonstrated  that  the  rapid  spreading observed  with 
activated  macrophages  can  be  induced  in  nonstimulated, resident  cells  by  factors 
generated in plasma upon activation of the contact  phase of blood coagulation or 
independently by activation of the complement system (14). 
In this report we further analyze the complement-dependent spreading reaction of 
mouse  peritoneal  macrophages  and  show  that  it  is  induced  by  the  enzymatically 
active b-fragment of factor B of the properdin system, i.e., the alternative pathway of 
complement activation. 
The results have in part been presented at the Seventh International Complement 
Workshop held in St. Petersburg, Florida in November 1977 (15). 
Materials and Methods 
Reagents.  EDTA,  kaolin,  inulin,  fetal  calf  serum  (FCS), 1  Dulbecco's  modified  Eagle's 
medium, H-21,  (DMEM)  were obtained as before (14). Medium RPMI-1640 was from Grand 
* Supported by U. S. Public Health Service grants AI 07007,  1507 PR-05514, AI 07012,  AI  12975, CA 
23056, and Rockefeller Foundation. 
:~ Recipient of a  grant-in-aid 76-846 of the American Heart Association, Work conducted during the 
tenure of an Established Investigatorship of the American Heart  Association, from the Department of 
Molecular Immunology, Research Institute of Scripps Clinic La Jolla, Calif. 92037. 
§ Recipient of a Career Development Award from The National Cancer Institute, CA 00463,  Depart- 
ment of Pathology, State University of New York,  Downstate Medical Center, Brooklyn, N. Y.  11203. 
i Abbreviations used in  this paper: A, anti-sheep E serum; AG LMe, acetyl-glycyl-lysy[-methyl ester; C3, 
third complement component; CVF, cobra venom factor; DFP, di-isopropylphosphofluoridate; DMEM, 
Dulbecco's modified Eagle's medium; DTT, dithiothreitol; E, sheep erythrocytes; FCS, fetal calf serum; 
aH-AG  LMe,  all-methyl acetyl  glycl-L-lysine  methyl ester-HCl;  PBS,  phosphate-buffered saline;  SDS- 
PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; VB, veronal buffer; Z, effective molecules 
of B/cell. 
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Island Biological Co., Grand Island, N. Y. Sheep erythrocytes (E) were from Colorado Serum 
Co., Denver, Colo.  Anti-sheep E serum (A) and its IgM fraction, respectively, were obtained 
from Cordis Laboratories, Inc., Miami, Fla. Antisera against whole mouse serum, mouse C3, 
mouse albumin, mouse transferrin, and mouse immunoglobulins  were obtained from Cappel 
Laboratories,  Inc., Cochranville, Pa.  Human blood was bought  from  the  New  York  Blood 
Center, New York. 
Di-isopropylphosphofluoridate (DFP), from Aldrich Chemical Co., Inc., Milwaukee, Wis., 
was diluted in propylene glycol.  1 mCi of ([all]methyl) acetyl glycl-L-lysine methyl ester-HCl 
(aH-AG LMe,  195  mCi/mmol) was  obtained from  Biochemical and  Nuclear Corporation, 
Burbank, Calif. It was dissolved in 1 ml water, further diluted 1/100 with water, and frozen in 
small aliquots at -70°C. Unlabeled AG LMe was from Sigma Chemical Co.,  St.  Louis, Mo. 
Dithiothreitol (DTT) was from Calbiochem, La Jolla, Calif. and reduced glutathione was from 
Boehringer, Mannheim Biochemicals, Indianapolis, Ind. Ion exchange celluloses,  DE 32 and 
CM 32 were from Whatman, Inc., Clifton, N. J. QAE-Sephadex A50 and Sephadex G150 were 
obtained from Pharmacia Fine Chemicals Inc., Piscataway, N. J.  and Bio Gel A-0.5  m  was 
from Bio-Rad Laboratories, Richmond, Calif. 
Purified Proteins.  Human C3 (16), C3b (17), factor B (18), factor D  (19) and cobra venom 
factor (CVF) (20) were purified according to published methods. Their purity was verified by 
sodium dodecyl sulfate polyacrylamide gel  electrophoresis  (SDS-PAGE)  in  7%  gels  and by 
immunochemical means. Mouse factor B was partially purified from mouse serum (Pel-Freez 
Farms Inc., Rogers,  Ark.) by column chromatography using in succession QAE-Sephadex A50, 
CM32-cellulose, and Biogel A-0.5 m. The final product was subjected to 6% alkaline PAGE. 
The gels were sliced  into 1.5-mm segments which were analyzed for the presence of factor B. 
Gel segments containing the active protein were emulsified with complete Freund's adjuvant 
(Difco Laboratories, Detroit, Mich.) and were used to raise antisera in rabbits. The two antisera 
obtained were found to be monospecific for mouse factor B when analyzed by double diffusion- 
in-gel and by immunoelectrophoresis using mouse serum and various concentrated fractions 
prepared  from  mouse serum  by column chromatography.  The antisera did  not  react  with 
antigens present in human serum. The IgG fractions of the anti-mouse B sera were obtained as 
the proteins not absorbed by DE32-cellulose at pH 7.3 and 0.005 M sodium phosphate. F(ab')2 
fragments were prepared from the purified IgG by pepsin digestion at pH 4 at a ratio of 3 mg 
pepsin (Worthington Biochemical Corp., Freehold, N. J.)  per  100 mg of protein as described 
(21). The F(ab')2 fragments were separated from other digestion products and from undigested 
IgG by gel filtration on Sephadex G150 and were stored at 4°C after their concentration to 0. 
20 of the original antiserum volume and the addition of 0.2% sodium azide. Before its use with 
macrophages the anti-B F(ab')2 was extensively dialyzed at 4°C against DMEM. 
Macrophage Spreading Assay.  This was performed as previously described (14) in RPMI-1640 
supplemented with 10% heat inactivated (1 h, 56°C) FCS. Cells were adjusted to 2  ×  106/ml 
and were plated (0.1 ml) on  13-mm round cover slips  (Clay Adams, Inc., Parsippany, N. J.). 
After incubation for  30  min at  37°C  in a  5%  CO2,  100% humidity atmosphere,  they were 
washed  three  times with  medium to  remove nonadherent cells.  The cover slips  were  then 
transferred to dry Petri dishes, were covered with 0.1  ml of medium or test solution and were 
further incubated for  1-2 h at 37°C. The cells were then fixed with 2.5% glutaraldehyde in 0.1 
M  cacodylate  buffer,  pH  7.4  and  were  left  under water  at  4°C  until cell  spreading was 
evaluated by phase-contrast microscopy by using the criteria described previously (14). 
Functional Assay for Factor B.  Factor B was assayed through its ability to form a stable CVF, 
Bb complex when incubated with purified CVF and factor D. The complex which was formed 
during a first incubation  step was then titered by its ability to induce lysis of glutathione-treated 
human erythrocytes in the presence of human EDTA-serum serving as a source of C3-9 (22). 
Factor B (0.2-10 #g factor D in a total vol of 0.21 ml GVBS-Mg for 30 min at 37°C). 0.1 ml of 
5 X  10S/ml glutathione-treated erythrocytes in GVBS-E and 0.2 ml human EDTA-serum (one 
part  0.2  M  EDTA, pH  7.4  +  nine parts normal human serum) were then added and the 
incubation continued for 30-60 min. The reaction was stopped by the addition of 2 ml of cold 
0.15 M  NaCI and the fraction of unlysed cells was determined spectrophotometrically at 541 
nm. Lysis was expressed  in effective  molecules of B/cell (Z). 
Radiochemical Assay for Factor B.  This was performed according to Imanari et al. (23) as based 
on the work of Roffman et al. (24). The assay is based on the fact that methanol generated by 374  THE  INDUCTION OF MACROPHAGE  SPREADING 
proteinase from [3H]methyl ester-containing substrates can be extracted into a  toluene-based 
scintillation cocktail and can then be measured in a liquid scintillation spectrometer. Unhydro- 
lyzed substrate  largely remains  in  the  aqueous  phase  and,  because  very small amounts  of 
substrate  are  used,  gives rise to  only  low  background  counts.  100  #1  Veronal  buffer  (VB) 
containing purified B or Bb was incubated at 37°C in tightly capped plastic tubes with 20 #1 
3H-AG LMe diluted with water such that 75 #1 of this mixture contained a total of 95,000-98,000 
cpm. The reaction was stopped by pipetting 75 #1 of the reaction mixture into scintillation vials 
containing  10  ml scintillation fluid and  50 #1  stop solution  (nine parts 0.01  M  AG LMe in 
water  +  one part glacial acetic acid). The scintillation vials were tightly capped, vigorously 
shaken  for  10  s,  and  were counted  in  a  refrigerated liquid scintillation spectrometer. Total 
counts were obtained by using dioxane-based Aquafluor (New England Nuclear Corp., Boston, 
Mass.) as the scintillation fluid. Liberated [3H]methanol was determined by using the toluene 
based scintillation fluid liquifluor (New England Nuclear Corp.). Kinetic experiments estab- 
lished that hydrolysis of AG LMe by Bb proceeds very slowly. Therefore,  16 h of incubation of 
37°C  was routinely used  for this assay. Controls for unspecific hydrolysis of substrate were 
carried through in all experiments and their results, 2.8-4.6% were subtracted appropriately. 
To keep unspecific hydrolysis low it was found necessary to filter-sterilize and boil all buffer 
solutions before use. 
PAGE.  Electrophoresis in 6% alkaline PAGE at pH 8.9 was performed as described (25). 
Gels from which protein was to be eluted were first subjected to electrophoresis for 2 h at 4°C. 
After replacing the electrode buffers, the samples (50-100 #l)  in  10% sucrose were layered on 
top of the gels.  Electrophoresis was continued until the tracking dye (bromphenyl blue) had 
reached the anodal end of the gels. For elution the gels were sliced into l-mm segments which 
were eluted overnight at 4°C with 0.1 ml PBS. Selected eluates were dialyzed against DMEM 
for 15 h at 4°C before their use in cell speading assays. SDS-PAGE in 7% gels was performed 
as described by Weber and Osborn (26).  All samples were boiled before electrophoresis for 5 
min in  1% SDS, 7  x  10 -3 M  DTT, 5 M  urea. The proteins used as molecular weight markers 
were human fibrinogen (kindly provided by Dr. P. C. Harpel, Cornell Medical College, New 
York) and soybean trypsin inhibitor (Worthington Biochemical Corp.). 
Radiolabeling.  Purified human factor B was radiolabeled with 12~I using the lactoperoxidase 
method  of David  and  Reisfeld  (27)  with  Sepharose-bound  lactoperoxidase  (Worthington 
Biochemical Corp.). 
Buffers 
PHOSPHATE-~UFFERED SALINE (r,  Bs). 0.14 M  NaC1 containing 0.01  M  sodium phosphate, pH 
7.2. Vns-Mg.  Isotonic veronal-buffered saline containing  10 -a M  MgCI2.  GvBs-Mg.  VBS- 
Mg containing 0.1%  gelatin. GvBs.  GVBS-Mg containing in addition  1.5  X  104  M  CaC12. 
Gv~s-e.  GVBS lacking divalent cations but containing 0.02 M  EDTA. 
Results 
Lack of Spreading Activity Generated  from Components of the Classical Pathway.  Previous 
experiments using CVF-activated serum had suggested that  the induction of macro- 
phage  spreading  might  be  due  to  activation  products  of  the  third  complement 
component  (C3)  and/or components of the alternative pathway because C 1, C2, and 
C4 are not grossly affected by the addition of CVF to plasma or serum and because 
a  role for C5 appeared to be excluded on the basis of results using serum  from  mice 
genetically  deficient  in  this  component.  To  substantiate  these  findings  109  EA 
prepared with IgM antibodies were incubated with (a) C1,  (b) C1  and C4, (c) C1, C2, 
C3,  and C4 and  (d)  C1,  C2,  C3,  C4,  and C5  in a  total vol of 1 ml. After 30 min at 
37°C  the  cells were  removed  by centrifugation  and  the  supernates  were  tested  for 
spreading activity. No activity was detected (Table I). 
Induction  of Macrophage Spreading  by  Activated Components of  the  Human Properdin 
System.  Because  of  the  failure  to  generate  macrophage  spreading  activity  from 
components of the classical pathway experiments with highly purified proteins of the O. GOTZE, C.  BIANCO, AND Z. A. COHN 
TASLE I 
Lack of Induction of Macrophage Spreading by Components of the Classical 
Complement Pathway 
Supernate from*  Macrophages spread~ 
% 
E IgM +  C I  7 
E IgM C1  +  C4  8 
EIgMCI4 +  C2 +  C3  6 
E IgM C1423 + C5  7 
* Supernates were prepared by incubation of 109 E IgM for 30 rain at 37°C 
with 10,000 U of guinea pig CI and  1,000 U of C4, C2, and C3 in PBS 
containing Ca  ++ and Mg  ÷÷. 
Determined after 1 h at 37°C in RPMI- 1640 containing 10% heat inactivated 
FCS. 
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alternative pathway were performed. Mixtures of human factor B, D, C3b, and C3 
were  incubated  in  VBS-Mg  for  30  min  at  37°C.  Consumption  of factor  B  and 
conversion of C3 were determined by titration  (factor B) and immunoelectrophoresis 
(C3)  in  1% agar. Both were found to be virtually complete in those mixtures which 
contained all essential factors, i.e., C3b, factor B and factor D. Residual factor B was 
0.1-1.18%  Z  of the  controls.  C3  was  completely  converted  to  the  more  anodally 
migrating C3b. Aliquots of all mixtures were tested for spreading activity in duplicate. 
Each  glass  cover slip  with  attached  macrophages  received  0. I  ml  of the  reaction 
mixtures diluted  in  DMEM  and containing  various combinations of 7.5/tg B, 0.15 
pg D,  7.5/~g C3b, and  15.1 #g C3. The results, presented in Table II, indicated  that 
macrophage spreading activity is generated only in mixtures which contain factor B 
together with cofactors necessary for the engagement of the positive feedback mech- 
anism of the properdin system. This mechanism involves first  the Mg++-dependent 
complex formation of C3b and factor B and secondly the cleavage of the complexed 
factor  B  by  factor  D  into  the  two  fragments,  Ba  and  Bb.  The  resulting  complex 
C3b, Bb  represents  the  labile  C3  convertase of the  properdin  system.  The  data  in 
Table II also suggests that C3a, the anaphylatoxin cleaved from C3 by the action of 
C3b, Bb,  is  not  required  for the  generation of spreading activity and  that  C3b  by 
itself is also inactive. 
Correlation of Spreading Activity  with  Activated  Factor B  (Bb).  The  next  series  of 
experiments  was  designed  to  establish  which  of  the  proteins  or  combinations  of 
proteins present in the active mixtures were able to initiate rapid spreading of freshly 
explanted  macrophages.  Fresh  frozen  human  serum  (230  ml)  was  thawed  and 
incubated for 30 min at 22°C with kaolin (1 mg/ml) to completely remove spreading 
activity  associated  with  the  contact  phase  of blood  coagulation.  To  the  absorbed 
serum was then added 0.32  mg of 125I-labeled  factor B  (37.6/ICi)  and 2.5  g packed, 
PBS-washed inulin particles. The inulin was dispersed in the serum and the mixture 
was incubated for 60 min at 37°C.  After removal of the inulin  particles by centrifu- 
gation  (30  min,  10,000  g),  the  supernate  was  dialyzed  against  0.005  M  sodium 
phosphate,  pH  7.3  (starting buffer)  and  applied  to a  5.8  ×  35  cm column  packed 
with DE 32-cellulose equilibrated  in the same buffer. The column was washed with 
3  liters of this buffer and was then  eluted  with  a  continuous  3.2L sodium  chloride 
gradient  made in starting buffer. 20-mi fractions were collected at a  flow rate of 60 376  THE  INDUCTION OF MACROPHAGE SPREADING 
TABLE  II 
Macrophage Spreading Induced by Purified Components of the Alternative 
Complement Pathway 
Components added*  Spreading:[: 
B 15 C3bC3 
B 15 C3b 
815 
15 C3b 
C3bC3 
B 
I5 
% 
72 
63 
18 
17 
9 
22 
20 
* Human purified components preincubated for 30 min at 37°C. Amounts 
used per assay: B, 7.5 ~tg; 15, 0.15/~g; C3b, 7.5/~g; C3, 15 #,g. All dilutions 
were made in PBS containing Ca  *+ and Mg  ++. 
:~ Determined after l h at 37°C in RPMI-  1640 containing 10% heat inactivated 
FCS. 
ml/h. The distribution  of 125I was determined by counting 0.5-ml aliquots of every 
second fraction in a  scintillation spectrometer. The results are shown in Fig.  1 (top). 
Three areas of radioactivity were found. Accordingly, three pools, A, B, and C  were 
made as  indicated.  They were each concentrated to 24 ml by pressure  filtration  in 
stirred  Amicon  cells  using  UM  10  membranes  for  pool  A  and  B  and  a  UM  2 
membrane for pool C  and were then dialyzed against PBS. Analysis of the pools by 
double-diffusion in gel and immunoelectrophoresis (both in  1% agarose) revealed the 
presence of Bb in pool A, of native B and Bb (in about equal amounts) in pool B and 
of Ba in pool C. Both pools B and C  also contained C3b as identified by immunoe- 
lectrophoresis (in  1% agar) whereas pool A did not react with antiserum to C3. When 
tested  for  the  induction  of macrophage spreading  both  pools  A  and  B  contained 
activity which was dose-related, with inhibition at higher concentrations, while pool 
C  was inactive  (Fig.  1,  bottom).  These  results,  together with  the  data  in  Table  II, 
strongly suggested that spreading activity was related to the b-fragment of factor B 
and that the presence of C3b was not required for its expression. 
Next,  10  ml  of pool A  was chromatographed on a  2  x  21  cm CM  32-cellulose 
column equilibrated  in 0.02  M  sodium phosphate, pH 6.0  (starting buffer). After a 
500-ml wash with the starting buffer  1 L NaC1 gradient made in starting buffer was 
applied.  10-ml Fractions were collected at a flow rate of 40 ml/h.  1 ml of each fraction 
was assayed for x25I. Aliquots of selected fractions were dialyzed against PBS and were 
then tested for the induction of macrophage spreading. The results of this experiment 
can be seen in Fig. 2, which shows a good correlation between the distribution of 12~I, 
i.e.,  Bb,  and spreading activity.  Fractions 59-66 were pooled, concentrated to 4 ml 
and  subjected  to  molecular  sieve  chromatography on  a  3.8  X  102  cm  column of 
Sephadex G  150 equilibrated  in PBS. 5.8-ml Fractions were collected at a  flow rate 
of 13 ml/h. The peak of 125I eluted at  764  ml together with the last  of four protein 
peaks.  When  tested  for  macrophage spreading  activity  very  good correlation  was 
again obtained between the distribution of t2~I and the presence of spreading activity 
in the column fractions (now shown). 
The active fractions from the gel  filtration column were pooled and concentrated 
to 2 ml. 0.1-ml Aliquots of this material were subjected to alkaline PAGE. At the end O.  GOTZE,  C.  BIANCO,  AND  Z.  A.  COHN 
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FIG.  1.  DEAE-cellulose chromatography of 12SI-B containing serum after inulin activation and 
evaluation of macrophage spreading activity of the ~2SI-containing  column pools. Upper panel: 230 
ml fresh frozen human serum containing 37.6 pCi 12SI-labeled factor B were activated with inulin 
and fractionated on DEAE-32 cellulose. Three separate ~2Sl-containing areas were identified at a 
conductance of 1.5, 5 and 15 mS pools A, B, and C. Lower panel: dose-response of the cell spreading 
activities of the 10-fold concentrated column pools. Pool A contained Bb, pool B contained factor 
B and Bb, and pool C contained Ba. 
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of the electrophoretic  run  the gels were sliced  into  1-mm segments and 0.1  ml  PBS 
was  added  to  each  of the  slices  before  they were  assayed  for  z25I. The  contents  of 
selected  tubes  were then  dialyzed against  DMEM  and were tested  for the ability to 
induce  macrophage  spreading.  The  results,  graphed  in  Fig.  3,  show  an  excellent 
correlation  of  radioactivity  (lzsI)  and  macrophage  spreading  activity.  Using  an 
antiserum to factor B only Bb was detected in this material by immunoelectrophoresis. 
The  molecular  weight  of the  125I-labeled  protein  in  the  Sephadex  G-150  pool  was 
estimated  by  SDS-PAGE  in  7.0%  gels.  50-~tl aliquots  of the  pooled  material  were 
boiled  in  SDS,  urea,  and  DTT  and  were  then  applied  to the  gels  in  25%  glycerol. 
After the  run  the  gels were sliced  into  1-mm segments  which were assayed  for l"SI. 
Replicate gels with marker proteins were stained with Coomassie Brilliant Blue G250 
and used for the construction of a  molecular weight-calibration curve. The mol wt of 
the  a2SI-labeled product of factor B  was estimated  to be 64,000  (Fig. 4),  in excellent 
agreement with previous determinations which, using the same method, had indicated 
a  mol wt of 63,000  (28). 
Analysis of Macrophage Spreading Activity Generated  from Highly Purified Human Factor 
B.  All the evidence accumulated so far pointed at the b-fragment of factor B as the 
inducer of macrophage spreading generated in complement-activated serum. To rule 
out  the possibility that  a  contaminating protein  which might copurify with  Bb was 
responsible  for the  induction  of cell  spreading,  rather  than  Bb  itself,  the  following 
purification procedure for Bb was adopted.  Bb was generated in mixtures of purified 
B,  D,  and  C3b  and  was  then  isolated  by  DE  32-cellulose  chromatography  which 
separates  the more basic Bb molecule from the more acidic native B as well as from 
Ba, D, and C3b all of which also elute later than  Bb. 4  mg B,  10/~g z25I B(1.18 pCi) 378  THE  INDUCTION  OF  MACROPHAGE SPREADING 
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FIG. 2.  Correlation of macrophage spreading activity and distribution of Bb upon CM-cellulose 
chromatography• Pool A from Fig. 1 was fractionated on CM-32 cellulose and the distribution of 
radioactivity (~I) in the fractions determined. After dialysis against PBS, selected fractions were 
tested for macrophage spreading activity• Both activities eluted at a conductance of 7.5 mS. 
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Flo. 3.  Correlation between macrophage spreading activity and distribution of Bb upon PAGE. 
125I-Bb containing Bb was purified from inulin activated serum by DE-32, CM-32, and Sephadex 
G-150 chromatography. 0. l-ml Aliquots of the active material were electrophoresed on 6% alkaline 
gels which were sliced into 1-ram segments. All gel segments  were assayed for 125I. Selected segments 
were eluted and dialyzed against PBS before their macrophage spreading activity was determined 
50 ~g D  and 1 mg C3b were incubated for 30 min at 37°C in VBS-Mg. The mixture 
was then dialyzed against 0.005 M  sodium phosphate, pH  7.3 and was applied to a 
1 ×  15 cm DE 32-cellulose column equilibrated in the same buffer. The column was 
washed  and  Bb  was  then  eluted  with  a  NaCl  gradient.  The  position  of  Bb  was 
determined by the distribution of 125I in the column eluates. The first 125I-containing 
peak contained Bb. It was pooled and concentrated to 0.8-1.25 mg/ml and dialyzed 
against PBS before storage at -70°C. Fig. 5 shows SDS-PAGE gels of the purified Bb 
obtained by this procedure. 
Dose-response experiments with such preparations of purified Bb yielded a  reason- 
ably straight line, 1.6 #g Bb being necessary to induce spreading of 50% of 5  X  104 
glass-attached macrophages (Fig. 6). O.  GOTZE,  C.  BIANCO,  AND  Z.  A.  COHN 
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FIG.  4.  Molecular weight estimation of Bb containing ~251-Bb purified from inulin activated serum. 
SDS-PAGE was performed in  7% acrylamide. After the run the gel was sliced in  1-mm segments 
which were assayed for 12sI. The inset shows the position of the 125I peak in relation to the mobilities 
and  mol wt  of the a,/~,  and  y-chains of fibrinogen  (70,900,  60,400,  and 49,400)  and of soybean 
trypsin inhibitor (21,000). 
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FIG.  5.  SDS-PAGE of Bb and its precursor factor  B.  Purified  factor  B  and its b-fragment  (Bb) 
prepared  from incubation mixtures of isolated C3b,  factor B and factor D  were analysed by SDS- 
PAGE in 7% acrylamide. 65 #g of the isolated proteins were applied to the gels which were stained 
with Coomassie Brilliant Blue G-250. The cathode was at the top. 380 
FIG.  6. 
THE  INDUCTION OF  MACROPHAGE  SPREADING 
Z 
90- 
70 
50 
30 
10 
0.1'5  0.:11  0.62  1.25  2~5  5  1'0 
MicroErams Bb 
Dose-response of isolated  Bb as an inducer of macrophage spreading. 
h 
Micrograms Bb 
7O 
5O 
~  30 
Z 
~  10 
'  ~  '  ~  '  ~  '  §  1'1 
Micrograms Bb 
Fro.  7.  Abrogation of the macrophage spreading  activity of isolated  Bb by its prior treatment 
with DFP. Isolated Bb was treated with DFP in propylene glycol at two different  concentrations or 
with  propylene glycol  alone and  was  dialyzed against  PBS.  (SH-methyl)  AG LMe hydrolyzing 
activity and macrophage spreading activity were determined in parallel.  ©, Bb; 0, Bb  +  5 X  10  -4 
DFP;A, Bb  +  2 ×  10  -aDFP. 
Requirement of the Intact Catalytic Site on Bb for Spreading Activity.  Two modes of action 
of Bb on macrophages were considered, enzymatic action of the serine protease Bb on 
a  cell  surface  substrate  and/or  binding  of  Bb  to  a  specific  cell  surface  structure 
(receptor).  While in screening experiments  unequivocal evidence for specific binding 
of ~25I-Bb  to  macrophages  could  not  be  obtained,  other experiments  suggested  that 
Bb  acted  as  an  enzyme.  It  was  observed  that  purified  Bb  which  had  spontaneously 
become inactive with respect  to its ability to hydrolyze AG LMe  had also lost its cell- 
spreading capacity.  More direct evidence came from experiments in which Bb-treated 
DFP  was  used.  Bb  generated  and  purified  from  isolated  B  as  described  was  treated O.  GOTZE,  C.  BIANCO,  AND  Z.  A.  COHN 
TABLE III 
Effect of Anti-Mouse B Fab'2 on Complement Induced Macrophage Spreading 
Microliter of Fab'2*  Percent macrophages spreads 
0  67 
10  56 
25  35 
80  15 
100  11 
150  10 
* Anti-B Fab'2 incubated for 15 min at 37°C with 0.1  ml mouse serum and  1 
U  CVF and then added to maerophage monolayers. The mouse serum had 
been pretreated with 10 mg kaolin/ml. 
$ Determined after  I h at 37°C. Controls with Fab'2 and CVF in the absence 
of serum showed spreading of 10% of the cells. 
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with the serine esterase inhibitor DFP (diluted in propylene glycol) for 1-2 h at 22°C. 
The treated material and a control treated only with propylene glycol were dialyzed 
against PBS at 4°C and were then tested for cell spreading and enzyme activity using 
aH-AG  LMe  as  a  substrate.  (In  some  experiments  in  which  only  3H-AG  LMe 
hydrolysis was tested, Bb was added to the substrate without prior dialysis.) As shown 
in Fig.  7, a  parallel decrease in aH-AG LMe-hydrolysis and macrophage-spreading 
activity was evident in samples treated with 5  X  104 M  or 2  X  10  -3 M  DFP. 
Macrophage Spreading Activity Derived  from Mouse Factor B.  In all previous experiments 
described here human complement components and mouse macrophages had  been 
used. In fact, because of the difficulties preparing sufficient amounts of purified mouse 
factor B and mouse cofactors it would have been quite laborious to work with both 
mouse cells and mouse proteins. That mouse factor B is involved in the spreading of 
mouse macrophages by complement-activated mouse serum was,  therefore, demon- 
strated indirectly. In these experiments F(ab')2 fragments prepared from the immu- 
noglobulins  of rabbit  antiserum  to  mouse  factor  B  were  used  to  block spreading 
activity. 0.1  ml of fresh, kaolin-absorbed mouse serum was incubated with 5 ~g CVF 
and increasing amounts of F(ab')2 anti-mouse B for  15 min at  37°C.  The mixtures 
were then diluted and added to macrophage monolayers. Cell spreading was deter- 
mined  after  60  rain  at  37°C.  The  results,  presented  in  Table  III,  indicated  that 
specific anti-mouse B antibody is able to abrogate the spreading activity generated in 
mouse serum by CVF. 
Discussion 
The experiments described here show that the enzymatically active b-fragment of 
the proteinase factor B of the properdin system, i.e., Bb, has the activity to induce 
rapid spreading of freshly explanted, nonstimulated, glass-attached mouse peritoneal 
macrophages. The findings confirm and  expand  previous observations which  dem- 
onstrated  the  presence  in  plasma  of  two  distinct  effector systems  which,  upon 
activation,  induced  rapid  spreading of adherent  mouse  macrophages  (14).  One  of 
these systems was found to be associated with the contact phase of blood coagulation, 
the  other  one  was  triggered  by  agents  which  activate  the  complement  reaction 
sequence.  The complement-dependent spreading  activity could  be  generated  by a 
variety of  substances which are known to activate either the classical, or the alternative, 382  THE INDUCTION OF MACROPHAGE SPREADING 
or both  pathways.  Thus,  sheep erythrocytes sensitized with  antibodies of the  IgM 
class  (EA), CVF,  inulin  particles, or zymosan were all  efficient in  generating cell- 
spreading activity in mouse plasma or serum obtained from either normal or geneti- 
cally C5-deficient animals. These results can now be explained by the production of 
Bb through the properdin system's positive feedback mechanism which is triggered 
by C3b (activated C3) regardless of its mode of generation. Once generated, C3b can 
associate with native factor B to form a complex, C3b, B in which B is susceptible to 
activation by limited proteolysis by the properdin system enzyme factor D or by other 
proteinases. Of the two cleavage products thus generated, Ba and Bb, the a-fragment 
is  released  whereas  the  b-fragment  remains  associated  with  C3b.  The  C3b, Bb 
complex, which constitutes the labile C3 convertase of the properdin pathway, decays 
quickly due to the dissociation of C3b and Bb. Free Bb, although still able to act on 
small substrates such as acetyl-glyeyl-lysyl-methyl ester (AG LMe)  (29), retains very 
little or no C3-cleaving activity (18, 30). 
The finding that  Bb which had spontaneously lost its AG LMe cleaving activity 
and DFP treated Bb do not possess cell spreading activity, together with the lack of 
evidence  for  125I-Bb binding  to  adherent  macrophages  (unpublished  observation) 
strongly suggested that Bb exerts its action on the cells through its enzyme activity. 
This proposed mode of action of Bb immediately raises the question as to the cellular 
substrate responsible for the observed phenomenon. In view of the limited specificity 
of the Bb enzyme the possibility has to be considered that one of the known substrates, 
i.e.,  C3  or C5  is  expressed on  the  macrophage surface and  is  activated  in  typical 
fashion. Such a hypothesis appears to be at variance with the fact that free Bb does 
neither act on C3  nor on C5  (18,  30, 31).  However, membrane-expressed C3 or C5 
could conceivably be cleaved by free Bb because the conformation of the membrane- 
associated  complement  components  might  differ from  that  of the  components  in 
solution. Thus, native C5  passively adsorbed to Raji lymphoblastoid cells has been 
shown by Dierich and Landen to be activated by erythrocytes carrying the classical 
complement  pathway  analogue  of C3b, Bb,  the  C4b, 2a  enzyme,  although  fluid 
phase C5 does also not serve as a substrate for the C4b, 2a  complex (32). The possible 
involvement of membrane-associated C3 or C5 in the macrophage spreading reaction 
is presently being explored. 
The cell-directed actions of factor B are not confined to its b-fragment. The smaller, 
more acidic a-fragment of guinea pig factor B has recently been shown by Hamuro et 
al.  to stimulate the directed migration of guinea pig peritoneal polymorphonuclear 
leukocytes in Boyden chambers although in these experiments relatively large amounts 
(10-21 #g) of Ba were required (33). 
Whereas macrophage spreading activity was consistently generated by purified Bb 
and could be observed under conditions which allowed the production of Bb, such 
activity could not be generated from the classical complement pathway analogue of 
factor B, the second component of complement (Table I). This is surprising because 
the  structure,  mode  of activation,  and  substrate  specificity  of C2  and  its  active 
cleavage product C2a are very similar or identical to that of factor B.  Both C2 and 
factor B consist of one polypeptide chain of approximately 100,000 daltons, both are 
proteolytically activated  by  complement  enzymes,  and  both  their  major  cleavage 
products  C2a  and  Bb, which  carry the  active sites  of the  enzymes, have  to  be  in 
complex with a second activated complement protein, C4b or C3b respectively, to be 
able to act on their natural substrates, the complement components C3 and C5.  In O. GOTZE, C.  BIANCO, AND Z. A. COHN  383 
addition,  the  structural  genes  for both  C2  and  factor B  are  present  on  the  same 
chromosome (chromosome 6 in man) and are linked to the major histocompatibility 
complex, the HLA region  (34-36).  The unresponsiveness of mouse macrophages to 
activated guinea pig C2  (Table I) remains unexplained at present. Conceivably, the 
difference between the effects of C2a and Bb with respect to macrophage spreading 
reflects the susceptibility of the membrane associated substrate  to these specialized 
proteinases. 
Almost all of  the results presented here have been obtained with mouse macrophages 
and  human  complement proteins.  In  fact, this study was  greatly facilitated by the 
finding  that  human  Bb,  which  can  be  prepared  in  milligram  amounts  in  highly 
purified form, is able to interact with mouse cells. Yet the involvement of mouse factor 
B in the previously studied spreading of mouse macrophages by complement-activated 
mouse  serum  (14)  could  be  demonstrated  indirectly  through  the  use  of a  rabbit 
antiserum specific for mouse factor B (Table III). 
The  effects of Bb  on  macrophages  have  recently been  confirmed with  purified 
human  peripheral  mononuclear phagocytes (monocytes)  (37).  In contrast to mouse 
peritoneal  macrophages  which  responded  immediately  to  Bb,  human  peripheral 
monocytes required  3-4  d  of culture before they spread  maximally in  response to 
human Bb, suggesting the requirement for an in vitro maturation process. 
Taken  together,  these  results  have  possible  implications  for  hypotheses  of the 
cooperation  between  monocytes  and  other  cells  of the  immune  system.  Human 
monocytes and animal macrophages have been shown to synthesize several comple- 
ment proteins, notably C2, C3, C4 and factor B and factor D  (38-41) and thus have 
themselves the potential to furnish all components required for the generation of Bb 
(19)  and their stimulation by this effector molecule (37).  Furthermore, Littman and 
Ruddy have shown that human peripheral blood mnonuclear cells respond with an 
earlier onset of C2  synthesis and  an  increase in  the amount  of C2  produced if the 
cultures were set up in the presence of antigen or if adherent monocytes were cultured 
in the presence of iymphokine-rich medium harvested from antigen-stimulated mono- 
nuclear cells (42). 
It is conceivable that the secretion of factor B is mediated by similar mechanisms, 
and the Bb is an active mediator of lymphocyte-macrophage interactions. Bb can be 
generated  by  proteinases  derived  from  cells  or  contained  and  activated  in  blood 
plasma either acting on C3, to generate C3b, or acting directly on Factor B, initiating 
locally the complement feedback system. Proteinases derived from activated cells or 
contained and activated in the blood plasma may act on C3 to generate C3b, or act 
directly on factor B, to locally initiate the complement feedback system, resulting in 
the production of complement cleavage products including Bb.  Such local comple- 
ment activation has a profound influence on macrophage motility. Studies presented 
separately, indicate that  Bb has migration inhibitory activity similar to that  of the 
macrophage  migration  inhibitory  factor in  a  capillary  migration  assay,  and  that 
migration inhibition or enhancement of migration are regulated by the local balance 
between Bb and C5a,  the chemotactic factor produced upon activation of C5  (43). 
In unpublished experiments it was found that pretreatment of mice with intrave- 
nous  injections  of CVF  such  that  their  complement  levels  as  detected  by  radial 
immunodiffusion were below 5% of normal, reduced the number of cells recovered 
from  the  peritoneal  cavity after  thioglycollate injection,  and  abrogated  the  rapid 
spreading  of  these  cells  making  them  appear  similar  to  normal,  nonstimulated 384  THE INDUCTION OF  MACROPHAGE SPREADING 
peritoneal macrophages. This suggests that Bb is one of several factors regulating the 
focussing and emigration of macrophages in inflammatory lesions and either promot- 
ing or facilitating their differentiation  into an activated cell with  microbicidal and 
cytocidal properties. 
Summary 
Unstimulated  mouse  peritoneal  macrophages attached  to  a  glass substratum  re- 
sponded to activated human factor B  (Bb) of the properdin system but not to native 
factor B with rapid spreading and a  concomitant  increase in their apparent surface 
area. Excellent correlation of the distribution of Bb protein and cell-spreading activity 
was found upon purification of Bb by ion-exchange and molecular seive chromatog- 
raphy  and  alkaline  polyacrylamide  gel  electrophoresis.  1.6  /~g  of purified  Bb  was 
sufficient to induce spreading in 50% of 5  x  104 glass attached macrophages within 
1-2 h at 37°C. Treatment of Bb with di-isopropyl-fluorophosphate indicated that the 
intact  catalytic  site  of the  serine-proteinase  Bb  was  required  for  the  initiation  of 
macrophage spreading.  The involvement of factor B  in  the  induction  of rapid  cell 
spreading could  also be indirectly  demonstrated  in  an  autologous system in  which 
F(ab')2 fragments of an antiserum  to mouse B  prevented mouse macrophages from 
spreading  in  response  to  complement-activated  mouse  serum.  These  experiments 
suggest a role for factor B and the alternative pathway of complement fixation in the 
localization of mononuclear phagocytes to areas of inflammation. 
Received  for publication 19 October 1978. 
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